The oral vaccine based on self-replicating RNA lipid nanoparticles can simultaneously neutralize both SARS-CoV-2 variants alpha and delta

The aim of this study was to evaluate self-replicating RNA lipid nanoparticles (saRNA LNPs) to neutralize SARS-CoV-2 variants delta (B.1.617 lineage) and alpha (B.1.1.7 lineage). Before immunization of mice with saRNA LNPs, we saw high expression of S-protein at both mRNA and protein levels after tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammadi, Golamabbas, Sotoudehnia Koranni, Zahra, Jebali, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495003/
https://www.ncbi.nlm.nih.gov/pubmed/34655852
http://dx.doi.org/10.1016/j.intimp.2021.108231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495003/
https://www.ncbi.nlm.nih.gov/pubmed/34655852
http://dx.doi.org/10.1016/j.intimp.2021.108231

Ejemplares similares